NCT03107585

Brief Summary

The investigators included prospectively 35 patients undergoing an intermediate cervical block under ultrasound (GP1) before a thyroidectomy ,compared to a group of 35 patients without a block (GP2).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

January 13, 2016

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

April 11, 2017

Completed
Last Updated

April 11, 2017

Status Verified

April 1, 2017

Enrollment Period

1 year

First QC Date

January 13, 2016

Last Update Submit

April 4, 2017

Conditions

Keywords

cervical plexus blockthyroidectomyopioid consumption

Outcome Measures

Primary Outcomes (1)

  • peroperative opioid consumption

    In addition to the standard monitoring , we associate that of narcosis (BIS, Covidien LLC.Mansfield, USA) whose level is maintained between 40 and 60, a monitoring of the capnia, maintained between 35 and 40mmHg, we associate an analyzer of gas.The maintenance of the anesthesia is provided by sevoflurane adjusted according to the values of the bi-spectral index. Remifentanil is administered by the electrical pump as a function of the variation in blood pressure and heart rate, which should not exceed 20% of their baseline values during the surgical procedure.All our patients were operated by the same team. Ten minutes before closure, each patient receives 1 g of paracetamol (Perfalgan®) and 50 to 100 mg of tramadol depending on his weight. The remifentanil syringe pump is stopped when the skin is closed and the total dose is calculated for each patient.

    opioid consumption during surgery

Secondary Outcomes (1)

  • postoperative opioid consumption

    first 24 hours after surgery

Study Arms (2)

bilateral cervical plexus block (GP1)

EXPERIMENTAL

arm intervention GP1 : after skin disinfection and oral premedication , ultrasound guided cervical bilateral bloc ,with10 ml of bupivacaine 0.25 was realized in each side of deep cervical space; then general anesthesia was performed with local protocol

Procedure: bilateral cervical plexus block

control(GP2)

PLACEBO COMPARATOR

GP2 control no specific intervention only general anesthesia was performed with local protocol

Procedure: bilateral cervical plexus block

Interventions

with a linear probe and after disinfection vascular neck axis are identified at first. At the cricoid cartilage we conducted an apical scan to locate the carotid bifurcation.at this level is carried out a lateral translation to the visibility of the deep cervical space below the sternocleidomastoidien muscle then a needle 50 is introduced in plane. we proceed in inundation of cervical space

Also known as: GP1
bilateral cervical plexus block (GP1)control(GP2)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • candidate for thyroidectomy
  • reoperation l

You may not qualify if:

  • no consent
  • BMI\> 34
  • allergy to any of the products used
  • reoperation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mahdia University Hospital

Mahdia, Mahdia Governorate, 5100, Tunisia

Location

Study Officials

  • ali majdoub, PHD

    tunisian ministery of health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

January 13, 2016

First Posted

April 11, 2017

Study Start

January 1, 2015

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

April 11, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations